Insiders SynAct Pharma AB

Equities

SYNACT

SE0008241491

Delayed Nasdaq Stockholm Other stock markets 06:50:06 2024-05-22 EDT			5-day change	1st Jan Change
7.185 ^SEK	-0.14%		-0.21%	-18.63%

04-23	Synact Pharma AB Announces Changes in Nomination Committee Ahead of the 2024 Annual General Meeting	CI
03-20	Sweden's SynAct Pharma Names New CEO	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Synact Pharma AB Announces Changes in Nomination Committee Ahead of the 2024 Annual General Meeting	04-23	CI
Sweden's SynAct Pharma Names New CEO	03-20	MT
SynAct Pharma AB Elects New Board Members and Chairman at Extraordinary General Meeting	03-20	CI
SynAct Pharma AB Announces CEO Changes	03-20	CI
SynAct Pharma AB Announces Resignation of Marina Bozilenko as Member of the Board of Directors	02-27	CI
SynAct Pharma Names New Chief Medical Officer	02-01	MT
Synact Pharma Appoints Kristen Harting as Chief Medical Officer, Effective 15 February 2024	02-01	CI
Synact Pharma Expands Its Rheumatology Clinical Advisory Board with Three New Highly Experienced Advisors	01-30	CI
SynAct Pharma AB Announces Appointments to Nomination Committee	11-22	CI
SynAct Pharma AB Announces Appointment of Thomas Von Koch as Board Member	23-05-25	CI
SynAct Pharma AB Appoints Björn Westberg as Chief Financial Officer	23-05-15	CI
SynAct Pharma AB Announces Executive Changes	23-04-03	CI
SynAct Pharma AB Introduces Resomelagon as Generic Name for AP1189	23-03-30	CI
Synact Pharma AB Announces Resignation of Patrik Renblad as Chief Financial Officer	23-02-01	CI
Change in Nomination Committee prior to AGM 2023 in SynAct Pharma	22-12-22	AQ
SynAct Pharma AB Announces Change in Nomination Committee Prior to Agm 2023	22-12-22	CI
Nomination Committee appointed ahead of AGM 2023 in SynAct Pharma AB	22-10-21	AQ
John Haurum Declines Re-Election as Board Member of SynAct Pharma AB	22-05-20	CI
The Nomination Committee proposes Kerstin Hasselgren as a new board member of SynAct Pharma AB	22-03-09	AQ
Synact Pharma Promotes Finance Vice President To CFO	22-01-07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders SynAct Pharma AB

Equities

SYNACT

SE0008241491

Insiders

Filters